Strong Quarterly Performance

GE HealthCare Technologies Inc. has announced an impressive start to fiscal 2025, with a 3% year-on-year revenue increase to $4.8 billion, surpassing market expectations.

Financial Highlights

The company's net income saw a significant jump of 50.8% compared to the same quarter in 2024, reaching $564 million. Diluted earnings per share (EPS) also rose by 51.85% annually to $1.23. In a move to return value to shareholders, GE HealthCare unveiled a $1 billion share repurchase program.

Strategic Growth and Acquisitions

"Our first quarter results demonstrate strong execution and robust growth across revenue, orders, and profit, particularly in the U.S. Our focus remains on advancing precision care and accelerating growth, highlighted by our recent acquisition of Nihon Medi-Physics. This acquisition is expected to enhance global access to our next-generation radiopharmaceuticals," stated CEO Peter Arduini.

Market Response

Following the announcement, GE HealthCare's stock price increased by 2.81% in premarket trading, reaching $70 per share at 6:29 am ET.